ArticleCureus2026
Preliminary Experience of Robotic Endometriosis From a Tertiary Care Center in India: The Learning Curve.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Endometriosis often requires surgery, especially in deep-infiltrating cases unresponsive to medical therapy. This study presents our institutional experience with robotic-assisted surgery (RAS) for endometriosis in Indian patients. Methodology This retrospective study was conducted at a high-volume tertiary care center in India and included patients who underwent robotic-assisted endometriosis surgeries using the da Vinci Xi system between October 2023 and April 2025. Results This study analyzed 108 patients, with 39.8% diagnosed with deep infiltrating endometriosis (DIE). The mean age and body mass index of the study groups were 40.9 ± 6.6 years and 26.3 ± 3.3 kg/m², respectively. The average operative time was 129.8 ± 56.0 minutes, with minimal intraoperative and postoperative complications (0.9% each), no conversions to open surgery, no wound infections, and no re-operations. Subgroup analysis revealed that DIE cases had longer operative times. Though complication rates and post-anesthesia care unit stay remained comparable to the non-DIE subgroup. Both subgroups demonstrated significant improvements in postoperative pain and quality of life scores (p < 0.001) compared to their preoperative values. The risk-adjusted cumulative sum analysis of operative and docking times demonstrated distinct learning phases, with marked improvements in surgical efficiency and operating room workflow over time. Notably, a marked inflection point was observed around case 28 in the DIE subgroup. While this subgroup may represent a particularly suitable cohort for the application of robotic techniques, these findings should be interpreted as reflective of procedural optimization within a carefully selected patient population rather than as a definitive statement of superiority. Conclusions This study confirms the feasibility, safety, and effectiveness of RAS for endometriosis in India, with significant postoperative improvements and low complication rates across all stages, including complex DIE cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.